The discovery of aspirin: a reappraisal

Walter Sneader

Research output: Contribution to journalArticlepeer-review

166 Citations (Scopus)
75 Downloads (Pure)


The discovery of aspirin is customarily said to have resulted from Felix Hoffmann's rheumatic father encouraging his son to produce a medicine devoid of the unpleasant effects of sodium salicylate. Hoffmann, a chemist in the pharmaceutical laboratory of the German dye manufacturer Friedrich Bayer & Co in Elberfeld, consulted the chemical literature and came across the synthesis of acetylsalicylic acid and then prepared the first sample of pure acetylsalicylic acid on 10 August 1897. This was marketed in 1899 under the registered trademark of Aspirin. This account of the discovery first appeared in 1934 as a footnote in a history of chemical engineering written by Albrecht Schmidt, a chemist who had recently retired from IG Farbenindustrie—the organisation into which F Bayer & Co had been incorporated in 1925.
Original languageEnglish
Pages (from-to)1591-1594
Number of pages4
Issue number7276
Publication statusPublished - 22 Dec 2000


  • anti-inflammatory agents, Non-Steroidal
  • aspirin
  • chemistry, pharmaceutical
  • Germany
  • 19th century
  • 20th century
  • biography
  • historical article


Dive into the research topics of 'The discovery of aspirin: a reappraisal'. Together they form a unique fingerprint.

Cite this